跳至主要内容
临床试验/NCT00981929
NCT00981929终止不适用

Development of Cocktail for Measuring the Activity of Important Cytochrome P450 Enzymes

University of Southern Denmark1 个研究点 分布在 1 个国家目标入组 412 人开始时间: 2009年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
412
试验地点
1
主要终点
Metabolic ratios

研究概览

简要总结

The Cytochrome P450 enzymes are responsible for the metabolism of a wide range of drugs and other xenobiotics. Genetic variants of the encoding P450 genes have shown to influence the rate of metabolism of many clinically used drugs.

The drugs tramadol, omeprazole, losartan, quinidine and caffeine reflect the activity of CYP2D6 (tramadol), CYP2C19 (omeprazole), CYP2C9 (losartan), CYP1A2 (caffeine) and CYP3A4/5 (quinidine).

The aim of the study is to investigate if the cocktail of tramadol, omeprazole, losartan and caffeine can be used to simultaneously determine the activity of CYP2D6, CYP2C19, CYP2C9 and CYP1A2. Furthermore, will the natural occurring 4-beta-hydroxy-cholesterol in the blood be measured as a metric for CYP3A4/5.

The study is divided in two. First part will include 12 healthy volunteers and consists of three arms separated by at least one week. In the first arm 50 mg of tramadol will be ingested and urine will be collected for 8 hours. In the second arm 20 mg omeprazole, 25 mg losartan and 200 mg caffeine will be ingested followed by 8 hours urine collection and a blood sample 4 hours after administration of the drugs. In the last arm 50 mg of tramadol, 20 mg omeprazole, 25 mg losartan and 200 mg caffeine will be ingested followed by 8 hours urine collection and a blood sample 4 hours after administration of the drugs.

Metabolic ratios will be calculated based on urine and plasma concentrations of the drugs and the relevant metabolites. Relevant genetic variants of the cytochrome P450 encoding genes will be determined.

If the metabolic ratios of the drugs are not significantly different between the arms, Second part of the study will be conducted.

This part is identical with the last arm and will include a maximum of 400 healthy volunteers: 50 mg of tramadol, 20 mg omeprazole, 25 mg losartan and 200 mg caffeine will be ingested followed by 8 hours urine collection and a blood sample 4 hours after administration of the drugs.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy volunteers,
  • Written consent, AND
  • Age 18-65 years old.

排除标准

  • Daily medication,
  • Alcohol abuse,
  • Pregnancy, OR
  • Breastfeeding.

研究组 & 干预措施

Tramadol

Active Comparator

CYP2D6 metric

干预措施: Tramadol (Drug)

Omeprazole, losartan, caffeine

Active Comparator

CYP2C19, CYP2C9 and CYP1A2 metrics

干预措施: Omeprazole, losartan, caffeine (Drug)

Tramadol, omeprazole, losartan and caffeine

Active Comparator

CYP2D6, CYP2C19, CYP2C9 and CYP1A2 metrics

干预措施: Tramadol, omeprazole, losartan, caffeine (Drug)

结局指标

主要结局

Metabolic ratios

时间窗: January 2011

次要结局

  • Genetic variants(January 2011)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Development of Cocktail for Measuring the Activity... | 临床试验